I’m pleased to announce that the Institutional Development Award Networks for Clinical and Translational Research (IDeA-CTR) funding opportunity announcement (PAR-20-175) has been reissued.
IDeA-CTR funds statewide or multistate regional networks that support:
Continue reading “Funding Opportunity: IDeA Networks for Clinical and Translational Research”
We’re pleased to announce that the Centers of Biomedical
Research Excellence (COBRE) Phase 3 funding opportunity announcement (FOA) (PAR-20-115) has been reissued.
COBRE supports thematic, multidisciplinary research centers
that establish and strengthen institutional biomedical research capacity in IDeA-eligible
states through three
sequential 5-year phases.
Continue reading “Funding Opportunity: Centers of Biomedical Research Excellence (COBRE) Phase 3”
UPDATE: The slides [PDF] from the recent webinar are now available.
NIGMS, in partnership with the Office of Research on Women’s Health (ORWH) and twelve other institutes and centers of NIH, invites applications for administrative supplements to eligible Institutional Development Award (IDeA) grants to address important issues of women’s health in the IDeA states. We encourage a broad range of research addressing women’s health issues with a special interest in maternal and infant mortality and morbidity, as well as their underlying causes.
Continue reading “Administrative Supplements for Research on Women’s Health in the IDeA States”
We’re pleased to announce that the IDeA Networks of Biomedical Research Excellence (INBRE) funding opportunity announcement (FOA) (PAR-20-102) has been reissued. INBRE fosters the development, coordination, and sharing of research resources and expertise that expand research opportunities and increase the number of competitive investigators in IDeA-eligible states. The program achieves these goals through partnerships between research-intensive and primarily undergraduate institutions, community colleges, and tribally controlled colleges and universities.
Continue reading “Funding Opportunity: IDeA Networks of Biomedical Research Excellence (INBRE)”
The Institutional Development Award (IDeA) program supports biomedical research and research capacity building in states and territories that historically have had low levels of NIH funding. The Centers of Biomedical Research Excellence (COBRE) are long-standing IDeA funding initiatives supporting thematic, multidisciplinary centers that establish and strengthen institutional biomedical research capacity via three sequential 5-year phases. Funding opportunity announcements for the first and second phases of COBRE were just reissued:
Continue reading “Funding Opportunity: Centers of Biomedical Research Excellence (COBRE), Phases 1 and 2”
UPDATE: The slides and video from the Regional Technology Accelerator Hubs Webinar have been posted.
If you or your institution are considering applying for our Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) funding opportunity—a new initiative designed to promote biomedical entrepreneurship—don’t miss our upcoming webinar:
Wednesday, November 15, from 3:00-4:30 p.m. ET.
During the webinar, NIGMS and Center for Scientific Review staff will explain the goals and objectives of the initiative and answer your questions. You are encouraged to submit questions by November 13 to Krishan Arora.
To access the webinar, visit the WebEx Meeting page (link no longer available) and enter the meeting number 620 731 655 and the password “nigms.” If you are unable to attend online, you can join by phone by calling 1-650-479-3208 from anywhere in the United States or Canada and entering the access code 628 562 389.
NIGMS Staff Participating in the November 15 Webinar:
Krishan K. Arora, Program Director, NIGMS
Joseph Gindhart, Program Director, NIGMS
Christy Leake, Grants Management Team Leader, NIGMS
Allen Richon, Scientific Review Officer, NIH Center for Scientific Review
Slides will be available on the IDeA website following the event.
We look forward to talking with you soon.
Each year, NIH nominates outstanding young scientists for the Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the U.S. government to scientists beginning their independent research careers. The scientists are selected for their innovative research record, potential to continue on this productive route and community service activities. Among this year’s PECASE recipients (nominated in 2014) are two NIGMS grantees, Tufts University’s Aimee Shen (who started her career at the University of Vermont) and Montana State University’s Blake Wiedenheft (who was the inaugural NIGMS Director’s Early Career Investigator Lecturer). Both scientists launched their labs with support from our Institutional Development Award (IDeA) program, which fosters health-related research and enhances the competitiveness of investigators at institutions in states with historically low levels of NIH funding.
Below, they answer questions about their research and community service efforts, offer advice to other early career scientists, and share their experiences with the IDeA program.
What is the focus of your research?
Blake Wiedenheft: Viruses that infect bacteria (i.e., bacteriophages) are the most abundant biological entities on earth. The selective pressures imposed by these pervasive predators have a profound impact on the composition and the behavior of microbial communities in every ecological setting. In my lab, we rely on a combination of techniques from bioinformatics, genetics, biochemistry and structural biology to understand the mechanisms that bacteria use to defend themselves from viral infection.
Aimee Shen: My lab studies Clostridium difficile, the leading cause of healthcare-associated infection in the United States. C. difficile forms metabolically dormant cells known as spores that allow the microbe to survive exit from the gastrointestinal tract of a mammalian host. My research is directed at understanding how C. difficile spores form in order to transmit infection and how they germinate and transform into disease-causing cells to initiate infection.
Continue reading “Q&A with NIGMS-Funded PECASE Winners”
NIH has launched a major new initiative called the Environmental Influences on Child Health Outcomes (ECHO) program to investigate environmental exposures on child health and development. An important component of the program will be the IDeA States Pediatric Clinical Trials Network (ISPCTN), which the Eunice Kennedy Shriver National Institute of Child Health and Human Development is leading in collaboration with us.
The ISPCTN will give medically underserved and rural populations access to state-of-the-art pediatric clinical trials. The network’s clinical trials sites, which will be located in states eligible for funding through our Institutional Development Award (IDeA) program, will receive support for the development of appropriate research infrastructure as well as supervised professional development in all aspects of clinical trials research and implementation. We expect the ISPCTN to help strengthen pediatric research opportunities and capacity in IDeA states, which historically have not received extensive NIH funding.
If you’re in an IDeA-eligible state (including Puerto Rico), we encourage you to apply to either or both of the ISPCTN FOAs:
Applications proposing studies on all pediatric diseases and conditions will be considered, but priority will be given to those on the focus areas and core elements of the ECHO program, which include upper and lower airway disease; obesity; pre-, peri-, and postnatal outcomes; and neurodevelopment. The application deadline for both announcements is April 15, 2016, with optional letters of intent due by March 15, 2016.
For more information about the ECHO program and its various FOAs, you can participate in webinars scheduled for January 14, 2016, and February 1, 2016, or contact one of us (firstname.lastname@example.org, email@example.com).